HF
AERI

HRT Financial’s Aerie Pharmaceuticals AERI Stock Holding History

HRT Financial’s Portfolio AERI Stock Details AERI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-96,705
Closed -$880K – 4037
2022
Q1 		$880K Sell
96,705
-52,750
-35% -$407K 0.01% 1169
2021
Q4 		$1.05M Buy
+149,455
New +$1.56M 0.01% 1066
2021
Q2 		– Sell
-10,139
Closed -$181K – 3761
2021
Q1 		$181K Buy
+10,139
New +$175K ﹤0.01% 2336
2020
Q3 		– Sell
-19,351
Closed -$285K – 2507
2020
Q2 		$285K Buy
+19,351
New +$286K 0.01% 1010

Other funds holding AERI

DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
JG
Jefferies Group New York $12B AUM 6.2% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

HRT Financial's AERI Position: Q2 2022 in Review

HRT Financial sold out of Aerie Pharmaceuticals (AERI) in Q2 2022, closing a stake of 96,705 shares — an estimated $880K sold.

HRT Financial first reported a position in AERI in Q2 2020 and held it in 4 quarters. The position peaked at $1.05M in Q4 2021. 137 funds tracked by Wall St. Rank hold AERI as of Q2 2022.

  • HRT Financial reported no remaining Aerie Pharmaceuticals position as of Q2 2022 after selling out during the quarter.
  • HRT Financial sold 96,705 Aerie Pharmaceuticals shares in Q2 2022, an estimated $880K.
  • HRT Financial first reported a position in Aerie Pharmaceuticals in Q2 2020 and held it in 4 quarters.
  • HRT Financial's Aerie Pharmaceuticals position peaked at $1.05M in Q4 2021.
  • 137 funds tracked by Wall St. Rank held Aerie Pharmaceuticals as of Q2 2022.

Based on HRT Financial's 13F filing for Q2 2022, filed 12 Aug 2022.